PREVENTION OF PERINATAL HIV TRANSMISSION - ARE THERE ALTERNATIVES TO PREPREGNANCY SEROLOGICAL SCREENING IN KINSHASA, ZAIRE

被引:10
|
作者
HASSIG, SE
KINKELA, N
NSA, W
KAMENGA, M
NDILU, M
FRANCIS, H
RYDER, RW
机构
[1] TULANE UNIV,SCH PUBL HLTH & TROP MED,NEW ORLEANS,LA 70118
[2] CTR DIS CONTROL,ATLANTA,GA 30333
[3] NIH,BETHESDA,MD 20892
关键词
Africa; AIDS; HIV; HIV screening; Perinatal transmission; Prevention; Zaire;
D O I
10.1097/00002030-199009000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complete obstetrical and medical histories were obtained from 6312 women between the ages of 15 and 45 years who had undergone HIV serological tests. Individual factors were examined for sensitivity, specificity and positive predictive value of HIV infection. No individual risk factors for HIV infection were identified which had sensitivities > 60%. Combinations of factors were modelled by logistic regression. Only a model which included indicators of present illness with AIDS/HIV-related symptoms (i.e., chronic fever, diarrhea or profound weight loss) was predictive of HIV serostatus. These results suggest that identification of healthy women at high risk of HIV infection using non-serological information is not feasible. Thus, since the yearly cost of universal serological screening is prohibitively expensive in the Zairean context, HIV/AIDS education and prevention campaigns may in fact be a more cost-effective means of preventing perinatal transmission of HIV.
引用
收藏
页码:913 / 916
页数:4
相关论文
共 50 条
  • [31] Prevention of perinatal transmission of human immunodeficiency virus (HIV) in Arkansas.
    Matheney, RC
    Tucker, NC
    Darville, T
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 57A - 57A
  • [32] Prevention of perinatal transmission of zidovudine- and nevirapine-resistant HIV
    Cha, Agnes
    Elsamadisi, Pansy
    Su, Christy Peggy
    Phipps, Emmet
    Birnbaum, Jeffrey M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (07) : 451 - 455
  • [33] VOLUNTARY BLOOD-DONOR RECRUITMENT - A STRATEGY TO REDUCE TRANSMISSION OF HIV-1, HEPATITIS-B AND SYPHILIS IN KINSHASA, ZAIRE
    JAGER, H
    NSEKA, K
    GOUSSARD, B
    KABEYA, CM
    RAUHAUS, G
    PEYERL, G
    SALAUN, JJ
    KORTE, R
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1990, 17 (04): : 224 - 226
  • [34] Prenatal Screening and Perinatal HIV Transmission in Northern Alberta, 1999-2006
    Hughes, Christine A.
    Zuk, Dalyce
    Foisy, Michelle
    Robinson, Joan
    Singh, Ameeta E.
    Houston, Stan
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 : S412 - S416
  • [35] Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo
    Gichane, Margaret W.
    Moracco, Kathryn E.
    Thirumurthy, Harsha
    Okitolonda, Emile W.
    Behets, Frieda
    Yotebieng, Marcel
    PLOS ONE, 2018, 13 (08):
  • [37] REPORT OF THE PREVENTION OF PERINATAL HIV TYPE-1 TRANSMISSION WORKSHOP - CONFERENCE SUMMARY
    ROBB, M
    BRIDGES, S
    MMIRO, F
    FOWLER, MG
    FAST, P
    MCNAMARA, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (10) : 1301 - 1303
  • [38] ANTI-HBC SCREENING FOR THE PREVENTION OF PERINATAL TRANSMISSION OF HEPATITIS-B VIRUS IN FRANCE
    DESCOS, B
    SCOTTO, J
    FAYOL, V
    HUET, JY
    PICHOUD, C
    HERMIER, M
    VILLE, G
    CHARVET, F
    DARGENT, D
    THOULON, JM
    TREPO, C
    INFECTION, 1987, 15 (06) : 434 - 439
  • [39] Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission
    Kuhn, L
    Sinkala, M
    Kankasa, MPHC
    Kasonde, P
    Thea, DM
    Aldrovandi, GM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (02) : 260 - 262
  • [40] Prevention of perinatal HIV transmission - Current status and future developments in anti-retroviral therapy
    Kourtis, AP
    DRUGS, 2002, 62 (15) : 2213 - 2220